Evidence map›Paper›PMID 40149271›Full record

ArticleCancers2025

Impact of the FIGO 2023 Staging System on the Adjuvant Treatment of Endometrial Cancer: A Comparative Analysis with FIGO 2009.

Federico Ferrari, Elisa Gozzini, Jacopo Conforti, Andrea Giannini, Fabio Barra, Anna Fichera, Filippo Alberto Ferrari, Hooman Soleymani Majd, Franco Odicino

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Federico FerrariDepartment of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.ORCID 0000-0001-7065-2432
Elisa GozziniDepartment of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.ORCID 0000-0003-4940-1959
Jacopo ConfortiDepartment of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.
Andrea GianniniUnit of Gynecology, Sant'Andrea Hospital, Department of Surgical and Medical Sciences and Translational Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0002-4388-0082
Fabio BarraUnit of Obstetrics and Gynecology, P.O. "Ospedale del Tigullio"-ASL4, Via Gio Batta Ghio 9, 16043 Genoa, Italy.
Anna FicheraDepartment of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.ORCID 0000-0002-7368-0823
Filippo Alberto FerrariDepartment of Obstetrics and Gynecology, Gynecologic Oncology and Minimally Invasive Pelvic Surgery, International School of Surgical Anatomy (ISSA), IRCCS "Sacro Cuore-Don Calabria" Hospital, 37024 Verona, Italy.ORCID 0000-0003-0726-1687
Hooman Soleymani MajdDepartment of Gynaecology Oncology, Oxford University Hospitals NHS Trust, Oxford OX3 7LE, UK.ORCID 0000-0003-3293-5321
Franco OdicinoDepartment of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant treatmentendometrial cancerFIGO staging systemProMisE

Identifiers

PMID40149271
PMCPMC11939940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.